BB BIOTECH AG : Notification and public disclosure of transactions by persons
05/27/2019 | 11:50am EST
|
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
27.05.2019 / 17:40
The issuer is solely responsible for the content of this announcement.
1. Details of the person discharging managerial responsibilities / person closely associated
a) Name | Title: |
Dr. |
| First name: |
Thomas |
| Last name(s): |
von Planta |
2. Reason for the notification
a) Position / status | Position: |
Member of the administrative or supervisory body |
b) Initial notification 3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name
b) LEI 4. Details of the transaction(s)
a) Description of the financial instrument, type of instrument, identification code | Type: |
Share |
| ISIN: |
CH0038389992 |
b) Nature of the transaction
c) Price(s) and volume(s) | Price(s) |
Volume(s) |
| 69.03 CHF |
61366.16 CHF |
d) Aggregated information | Price |
Aggregated volume |
| 69.03 CHF |
61366.16 CHF |
e) Date of the transaction
f) Place of the transaction | Name: |
SIX Swiss Exchange |
| MIC: |
XSWX |
27.05.2019 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
|
| Language: |
English |
| Company: |
BB BIOTECH AG |
|
Schwertstrasse 6 |
|
8200 Schaffhausen |
|
Switzerland |
| Internet: |
www.bbbiotech.ch |
| |
| End of News |
DGAP News Service |
51397 27.05.2019
© EQS 2019
| Latest news on BB BIOTECH AG |
|
|
| |
|
|
|
| Sales 2019 |
209 M |
| EBIT 2019 |
297 M |
| Net income 2019 |
321 M |
| Debt 2019 |
85,0 M |
| Yield 2019 |
4,01% |
|
| P/E ratio 2019 |
14,5x |
| P/E ratio 2020 |
22,8x |
| EV / Sales2019 |
18,2x |
| EV / Sales2020 |
1 900x |
| Capitalization |
3 715 M |
|
|
|
|
Duration :
Period :
|
 | |
|
Technical analysis trends BB BIOTECH AG
| Short Term | Mid-Term | Long Term | | Trends | Bullish | Bullish | Neutral |
Income Statement Evolution
| Mean consensus |
HOLD |
| Number of Analysts |
3 |
| Average target price |
74,50 CHF |
| Last Close Price |
67,05 CHF |
| Spread / Highest target |
23,8% |
| Spread / Average Target |
11,1% |
| Spread / Lowest Target |
-1,57% |
|
United Kingdom
Canada
France
Deutschland
Schweiz (DE)
Report 
